Management of obesity explained

Management of obesity can include lifestyle changes, medications, or surgery. Although many studies have sought effective interventions, there is currently no evidence-based, well-defined, and efficient intervention to prevent obesity.[1]

Treatment for obesity often consists of weight loss via healthy nutrition and increasing physical exercise.[2] [3] [4] [5] A 2007 review concluded that certain subgroups, such as those with type 2 diabetes and women who undergo weight loss, show long-term benefits in all-cause mortality, while long‐term outcomes for men are "not clear and need further investigation."[6]

The most effective treatment for obesity is bariatric surgery.[7] Surgery for severe obesity is associated with long-term weight loss and decreased overall mortality. One study found a weight loss of between 14% and 25% (depending on the type of procedure performed) at 10 years, and a 29% reduction in all cause mortality when compared to standard weight loss measures.[8] Another study also found reduced mortality in those who underwent bariatric surgery for severe obesity.[9]

In June 2021, the US Food and Drug Administration (FDA) approved semaglutide injection sold under the brand name Wegovy for long-term weight management in adults. It is associated with a loss of 6-12% body weight along with mild gastrointestinal side effects.[10] [11]

Another medication, orlistat, is widely available and approved for long-term use. Its use produces modest weight loss, with an average of 2.9kg (06.4lb) at 1 to 4 years, but there is little information on how these medications affect longer-term complications of obesity.[12] Its use is associated with high rates of gastrointestinal side effects.

Diet programs can produce short-term weight loss and, to a lesser extent, over the long-term. Greater weight loss results, including amongst underserved populations, are achieved when proper nutrition is regularly combined with physical exercise and counseling.[13] Dietary and lifestyle changes are effective in limiting excessive weight gain in pregnancy and improve outcomes for both the mother and the child.[14]

Dieting

See main article: Dieting.

Treatment selection based on BMI[15] [16] !Treatment!25-26.9!27-29.9!30-34.9!35-39.9!≥40
Lifestyle intervention
(diet, physical activity,
behavior)		YesYesYesYesYes
PharmacotherapyNot appropriateWith co-morbiditiesYesYesYes
SurgeryNot appropriateNot appropriateNot appropriateWith co-morbiditiesYes

Diets to promote weight loss can be divided into four categories: low-fat, low-carbohydrate, low-calorie, and very low calorie.[17] Many dietary patterns are effective. A meta-analysis of six randomized controlled trials found no difference between three of the main diet types (low calorie, low carbohydrate and low fat), with a 2kg–4kgkg (04lb–09lbkg) weight loss in all studies.[17] At two years these three methods resulted in similar weight loss irrespective of the macronutrients emphasized.[18] High protein diets do not appear to make any difference.[19] A diet high in added sugars such as those in soft drinks increases weight.[20] There is evidence that dieting alone can be effective for weight loss and improving health for obese individuals.[21] However, a large study of adults found that obesity was associated with differences in brain structure, largely due to shared genetic factors, suggesting that interventions for obesity should not focus solely on energy content, but also take into account the neurobehavioral profile that obesity is genetically associated with.[22]

Dieting for calorie restriction is advised for overweight individuals by the Dietary Guidelines for Americans and United Kingdom's NICE.[23]

Exercise

With use, muscles consume energy derived from both fat and glycogen. Due to the large size of leg muscles, walking, running and cycling are the most effective means of exercise to reduce body fat.[24] Exercise affects macronutrient balance. During moderate exercise, equivalent to a brisk walk, there is a shift to greater use of fat as a fuel.[25] [26] To maintain health, the American Heart Association recommends a minimum of 30 minutes of moderate exercise at least 5 days a week.

The Cochrane Collaboration found that exercising alone led to limited weight loss. In combination with diet, however, it resulted in a 1 kilogram weight loss over dieting alone. A 1.5kg (03.3lb) loss was observed with a greater degree of exercise.[27] Even though exercise as carried out in the general population has only modest effects, a dose response curve is found and very intense exercise can lead to substantial weight loss. During 20 weeks of basic military training with no dietary restriction, obese military recruits lost 12.5kg (27.6lb).[28] High levels of physical activity seem to be necessary to maintain weight loss.[29] A pedometer appears useful for motivation. Over an average of 18-weeks of use, physical activity increased by 27% resulting in a 0.38 decrease in BMI.[30]

Signs that encourage the use of stairs as well as community campaigns have been shown to be effective in increasing exercise in a population.[31] The city of Bogota, Colombia, for example, blocks off 113km (70miles) of roads every Sunday and on holidays to make it easier for its citizens to get exercise. These pedestrian zones are part of an effort to combat chronic diseases, including obesity.[32]

In an effort to combat the issue, a primary school in Australia instituted a standing classroom in 2013.[33]

There is evidence that exercise alone is not sufficient to produce meaningful weight loss, but combining dieting and exercise provide the greatest health benefits and weight loss on the long term.

Weight loss programs

Weight loss programs involve lifestyle changes including diet modifications, physical activity and behavior therapy. This may involve eating smaller meals, cutting down on certain types of food and making a conscious effort to exercise more. These programs also enable people to connect with a group of others who are attempting to lose weight, in the hopes that participants will form mutually motivating and encouraging relationships.[34] Since 2013, the United States guidelines recommend treating obesity as a disease and actively treat obese people for weight loss.

A number of popular programs exist including Weight Watchers, Overeaters Anonymous and Jenny Craig. These appear to provide modest weight loss (2.9abbr=onNaNabbr=on) over dieting on one's own (0.2abbr=onNaNabbr=on) over a two-year period,[35] [36] [37] [38] similarly to non-commercial diets. As of 2005, there was insufficient scientific evidence to determine whether Internet-based programs produce effective weight loss.[39] The Chinese government has introduced a number of "fat farms" where obese children go for reinforced exercise and has passed a law which requires students to exercise or play sports for an hour a day at school (see Obesity in China).[40] [41]

In a structured setting with a trained therapist, these interventions produce an average weight loss of up to 8 kg in 6 months to 1 year, and 67% of people who lost greater than 10% of their body mass maintained or continued to lose weight one year later.[42] There is a gradual weight regain after the first year of about 1 to 2 kg per year, but on the long-term this still results in weight loss. Risk factors for cardiovascular disease and for diabetes are reduced for several years after taking part in a weight management programme, even if people regained weight.[43] [44]

Attending group meetings for weight reduction programmes rather than receiving one-on-one support may increase the likelihood that obese people will lose weight. Those who participated in groups had more treatment time and were more likely to lose enough weight to improve their health. Study authors suggested that one explanation for the difference is that group participants spent more time with the clinician (or whoever delivered the programme) than those receiving one-on-one support.[45] [46]

Comprehensive diet programs, providing counseling, targets for calorie intake and exercise, may be more efficient than dieting without guidance ("self-help"),[47] [48] although the evidence is very limited.[49] Following comprehensive lifestyle modifications, the average maintained weight loss is more than 3kg (07lb) or 3% of total body mass, and could be sustained for five years,[50] and up to 20% of the individuals maintain a weight loss of at least 10% (average of 33 kg).[51] There is some evidence that fast weight loss produce greater long-term weight loss than gradual weight loss. Moderate on-site comprehensive lifestyle changes produce a greater weight loss than usual care, of 2 to 4 kg on average in 6 to 12 months. High-intensity comprehensive programs usually yield more weight loss than moderate or low-intensity, with about 35% to 60% of overweight individuals maintaining more than 5 kg weight loss after 2 years.

The NICE devised a set of essential criteria to be met by commercial weight management organizations to be approved.[52]

The Transtheoretical Model (TTM) has been used as a framework to assist the design of lifestyle modification programmes, including weight management. A systematic review found that there is insufficient evidence to draw conclusions regarding the effects of TTM-based programs targeting weight loss that included dietary or physical activity interventions, or both (and also combined with other interventions), on sustainable weight loss (one year or longer) in overweight and obese adults. However, very low quality evidence points that this approach may induce positive changes in physical activity and dietary habits, such as increased in exercise duration and frequency, improvement in fruits and vegetables consumption, and reduced dietary fat intake.[53]

Medication

See main article: Anti-obesity medication.

Anti-obesity medications currently approved by the FDA for weight loss

Several anti-obesity medications are currently approved by the FDA for long term use.[54] [55] [56]

Other medications

Surgery

See main article: Bariatric surgery.

Bariatric surgery ("weight loss surgery") is the use of surgical intervention in the treatment of obesity. As every operation may have complications, surgery is only recommended for severely obese people (BMI > 40) who have failed to lose weight following dietary modification and pharmacological treatment. Weight loss surgery relies on various principles: the two most common approaches are reducing the volume of the stomach (e.g. by adjustable gastric banding and vertical banded gastroplasty), which produces an earlier sense of satiation, and reducing the length of bowel that comes into contact with food (e.g. by gastric bypass surgery or endoscopic duodenal-jejunal bypass surgery[76] [77]), which directly reduces absorption. Band surgery is reversible, while bowel shortening operations are not. Some procedures can be performed laparoscopically. Complications from weight loss surgery are frequent.[78]

Surgery for severe obesity is associated with long-term weight loss and decreased overall mortality. One study found a weight loss of between 14% and 25% (depending on the type of procedure performed) at 10 years, and a 29% reduction in all cause mortality when compared to standard weight loss measures.[8] A marked decrease in the risk of diabetes mellitus, cardiovascular disease and cancer has also been found after bariatric surgery.[8] [79] Marked weight loss occurs during the first few months after surgery, and the loss is sustained in the long term. In one study there was an unexplained increase in deaths from accidents and suicide, but this did not outweigh the benefit in terms of disease prevention.[79] When the two main techniques are compared, gastric bypass procedures are found to lead to 30% more weight loss than banding procedures one year after surgery.[80] For obese individuals with non-alcoholic fatty liver disease (NAFLD), bariatric surgery improves or cures the liver.[81] [82]

A preoperative diet such as low-calorie diets or very-low-calorie diet, is usually recommended to reduce liver volume by 16-20%, and preoperative weight loss is the only factor associated with postoperative weight loss.[83] [84] Preoperative weight loss can reduce operative time and hospital stay.[85] [86] although there is insufficient evidence whether preoperative weight loss may be beneficial to reduce long-term morbidity or complications.[87] Weight loss and decreases in liver size may be independent from the amount of calorie restriction.

Ileojejunal bypass, in which the digestive tract is rerouted to bypass the small intestine, was an experimental surgery designed as a remedy for morbid obesity.

The effects of liposuction on obesity are less well determined. Some small studies show benefits[88] while others show none.[89] A treatment involving the placement of an intragastric balloon via gastroscopy has shown promise. One type of balloon led to a weight loss of 5.7 BMI units over 6 months or 14.7kg (32.4lb). Regaining lost weight is common after removal, however, and 4.2% of people were intolerant of the device.[90]

An implantable nerve simulator which improves the feeling of fullness was approved by the FDA in 2015.[91]

In 2016 the FDA approved an aspiration therapy device that siphons food from the stomach to the outside and decreases caloric intake.[92] As of 2015 one trial shows promising results.[93]

Health policy

Obesity is a complex public health and policy problem because of its prevalence, costs, and health effects.[94] As such, managing it requires changes in the wider societal context and effort by communities, local authorities, and governments.[95] Public health efforts seek to understand and correct the environmental factors responsible for the increasing prevalence of obesity in the population. Solutions look at changing the factors that cause excess food energy consumption and inhibit physical activity. Efforts include federally reimbursed meal programs in schools, limiting direct junk food marketing to children,[96] and decreasing access to sugar-sweetened beverages in schools.[97] The World Health Organization recommends the taxing of sugary drinks.[98] When constructing urban environments, efforts have been made to increase access to parks and to develop pedestrian routes.[99]

Mass media campaigns seem to have limited effectiveness in changing behaviors that influence obesity. At the same time they can increase knowledge and awareness regarding physical activity and diet, which might lead to changes in the long term. Campaigns might also be able to reduce the amount of time spent sitting or lying down and positively affect the intention to be active physically.[100] [101] Nutritional labelling with energy information on menus might be able to help reducing energy intake while dining in restaurants.[102]

Since there is a relationship between obesity and automobile travel, interventions relating to transportation infrastructure (for example, policy aimed at encouraging the use of public transportation) could potentially reduce obesity.[103] [104]

Clinical protocols

Much of the Western world has created clinical practice guidelines in an attempt to address rising rates of obesity. Australia,[105] Canada,[5] the European Union,[106] the United Kingdom, [107] and the United States have all published statements since 2004.

In a clinical practice guideline by the American College of Physicians, the following five recommendations are made:[108]

  1. People with a BMI of over 30 should be counseled on diet, exercise and other relevant behavioral interventions, and set a realistic goal for weight loss.
  2. If these goals are not achieved, pharmacotherapy can be offered. The person needs to be informed of the possibility of side-effects and the unavailability of long-term safety and efficacy data.
  3. Drug therapy may consist of sibutramine, orlistat, phentermine, diethylpropion, fluoxetine, and bupropion. Evidence is not sufficient to recommend sertraline, topiramate, or zonisamide.
  4. In people with a BMI over 40 who fail to achieve their weight loss goals (with or without medication) and who develop obesity-related complications, referral for bariatric surgery may be indicated. The person needs to be aware of the potential complications.
  5. Those requiring bariatric surgery should be referred to high-volume referral centers, as the evidence suggests that surgeons who frequently perform these procedures have fewer complications.

A clinical practice guideline by the US Preventive Services Task Force (USPSTF) concluded that the evidence is insufficient to recommend for or against routine behavioral counseling to promote a healthy diet in unselected people in primary care settings, but that intensive behavioral dietary counseling is recommended in those with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease. Intensive counseling can be delivered by primary care clinicians or by referral to other specialists, such as nutritionists or dietitians.[109] [110] A survey of primary care physicians in the United States[111] found that although clinical guidelines do not consider overweight to be a risk factor that increases mortality,[112] physicians often report believing that being overweight increases all-cause mortality.

Canada developed and published evidence-based practice guidelines in 2006. The guidelines attempt to address the prevention and management of obesity at both the individual and population levels in both children and adults.[5] The European Union published clinical practice guidelines in 2008 in an effort to address the rising rates of obesity in Europe.[106] Australia came out with practice guidelines in 2004.[105]

Notes and References

  1. Chiolero A . Why causality, and not prediction, should guide obesity prevention policy . The Lancet. Public Health . 3 . 10 . e461–e462 . October 2018 . 30177480 . 10.1016/S2468-2667(18)30158-0 . free .
  2. Web site: US Department of Health and Human Services. . 2015–2020 Dietary Guidelines for Americans - health.gov . health.gov . Skyhorse Publishing Inc. . 30 September 2019 . 2017.
  3. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B . 6 . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines . Circulation . 140 . 11 . e596–e646 . September 2019 . 30879355 . 7734661 . 10.1161/CIR.0000000000000678 . free . Michelle Albert .
  4. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF . 6 . 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society . Circulation . 129 . 25 Suppl 2 . S102–S138 . June 2014 . 24222017 . 5819889 . 10.1161/01.cir.0000437739.71477.ee .
  5. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E . 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] . CMAJ . 176 . 8 . S1-13 . April 2007 . 17420481 . 1839777 . 10.1503/cmaj.061409 . Obesity Canada Clinical Practice Guidelines Expert Panel .
  6. Poobalan AS, Aucott LS, Smith WC, Avenell A, Jung R, Broom J . Long-term weight loss effects on all cause mortality in overweight/obese populations . Obesity Reviews . 8 . 6 . 503–513 . November 2007 . 17949355 . 10.1111/j.1467-789X.2007.00393.x . 42859237 .
  7. Colquitt JL, Pickett K, Loveman E, Frampton GK . Surgery for weight loss in adults . The Cochrane Database of Systematic Reviews . 2014 . 8 . CD003641 . August 2014 . 25105982 . 9028049 . 10.1002/14651858.CD003641.pub4 .
  8. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM . 6 . Effects of bariatric surgery on mortality in Swedish obese subjects . The New England Journal of Medicine . 357 . 8 . 741–752 . August 2007 . 17715408 . 10.1056/NEJMoa066254 . 20533869 . free .
  9. Peeters A, O'Brien PE, Laurie C, Anderson M, Wolfe R, Flum D, MacInnis RJ, English DR, Dixon J . 6 . Substantial intentional weight loss and mortality in the severely obese . Annals of Surgery . 246 . 6 . 1028–1033 . December 2007 . 18043106 . 10.1097/SLA.0b013e31814a6929 . 21151854 .
  10. Web site: Office of the Commissioner . 2021-06-21 . FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 . 2022-07-21 . FDA . en.
  11. Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF . 6 . Once-Weekly Semaglutide in Adults with Overweight or Obesity . The New England Journal of Medicine . 384 . 11 . 989–1002 . March 2021 . 33567185 . 10.1056/NEJMoa2032183 . 231883214 . free .
  12. Rucker D, Padwal R, Li SK, Curioni C, Lau DC . Long term pharmacotherapy for obesity and overweight: updated meta-analysis . BMJ . 335 . 7631 . 1194–1199 . December 2007 . 18006966 . 2128668 . 10.1136/bmj.39385.413113.25 .
  13. Katzmarzyk PT, Martin CK, Newton RL, Apolzan JW, Arnold CL, Davis TC, Price-Haywood EG, Denstel KD, Mire EF, Thethi TK, Brantley PJ, Johnson WD, Fonseca V, Gugel J, Kennedy KB, Lavie CJ, Sarpong DF, Springgate B . 6 . Weight Loss in Underserved Patients - A Cluster-Randomized Trial . The New England Journal of Medicine . 383 . 10 . 909–918 . September 2020 . 32877581 . 7493523 . 10.1056/NEJMoa2007448 .
  14. Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, Mol BW, Coomarasamy A, Khan KS . 6 . Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence . BMJ . 344 . e2088 . May 2012 . 22596383 . 3355191 . 10.1136/bmj.e2088 .
  15. Matarese LE, Pories WJ . Adult weight loss diets: metabolic effects and outcomes . Nutrition in Clinical Practice . 29 . 6 . 759–767 . December 2014 . 25293593 . 10.1177/0884533614550251 . Review .
  16. Book: The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 2000. National Institutes of Health, National Heart, Lung, and Blood Institute, NHLBI Obesity Education Initiative, North American Association for the Study of Obesity. en. National guidelines.
  17. Strychar I . Diet in the management of weight loss . CMAJ . 174 . 1 . 56–63 . January 2006 . 16389240 . 1319349 . 10.1503/cmaj.045037 .
  18. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA . 6 . Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates . The New England Journal of Medicine . 360 . 9 . 859–873 . February 2009 . 19246357 . 2763382 . 10.1056/NEJMoa0804748 .
  19. Schwingshackl L, Hoffmann G . Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis . Nutrition Journal . 12 . 48 . April 2013 . 23587198 . 3636027 . 10.1186/1475-2891-12-48 . free .
  20. Te Morenga L, Mallard S, Mann J . Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies . BMJ . 346 . e7492 . January 2012 . 23321486 . 10.1136/bmj.e7492 . free . 20.500.12799/4871 . free .
  21. Thom G, Lean M . Is There an Optimal Diet for Weight Management and Metabolic Health? . Gastroenterology . 152 . 7 . 1739–1751 . May 2017 . 28214525 . 10.1053/j.gastro.2017.01.056 . Review .
  22. Vainik U, Baker TE, Dadar M, Zeighami Y, Michaud A, Zhang Y, García Alanis JC, Misic B, Collins DL, Dagher A . 6 . Neurobehavioral correlates of obesity are largely heritable . Proceedings of the National Academy of Sciences of the United States of America . 115 . 37 . 9312–9317 . September 2018 . 30154161 . 6140494 . 10.1073/pnas.1718206115 . free . 2018PNAS..115.9312V .
  23. Web site: Obesity: maintaining a healthy weight and preventing excess weight gain . pathways.nice.org.uk. 8 March 2023 .
  24. Gwinup G . Weight loss without dietary restriction: efficacy of different forms of aerobic exercise . The American Journal of Sports Medicine . 15 . 3 . 275–279 . 1987 . 3618879 . 10.1177/036354658701500317 . 1973279 .
  25. Sahlin K, Sallstedt EK, Bishop D, Tonkonogi M . Turning down lipid oxidation during heavy exercise--what is the mechanism? . Journal of Physiology and Pharmacology . 59 . Suppl 7 . 19–30 . December 2008 . 19258655 .
  26. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A . 6 . Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association . Circulation . 116 . 9 . 1081–1093 . August 2007 . 17671237 . 10.1161/CIRCULATIONAHA.107.185649 . free .
  27. Shaw K, Gennat H, O'Rourke P, Del Mar C . Exercise for overweight or obesity . The Cochrane Database of Systematic Reviews . 2006 . 4 . CD003817 . October 2006 . 17054187 . 9017288 . 10.1002/14651858.CD003817.pub3 .
  28. Lee L, Kumar S, Leong LC . The impact of five-month basic military training on the body weight and body fat of 197 moderately to severely obese Singaporean males aged 17 to 19 years . International Journal of Obesity and Related Metabolic Disorders . 18 . 2 . 105–109 . February 1994 . 8148923 .
  29. Bessesen DH . Update on obesity . The Journal of Clinical Endocrinology and Metabolism . 93 . 6 . 2027–2034 . June 2008 . 18539769 . 10.1210/jc.2008-0520 . free .
  30. Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR . 6 . Using pedometers to increase physical activity and improve health: a systematic review . JAMA . 298 . 19 . 2296–2304 . November 2007 . 18029834 . 10.1001/jama.298.19.2296 . 3008531 .
  31. Kahn EB, Ramsey LT, Brownson RC, Heath GW, Howze EH, Powell KE, Stone EJ, Rajab MW, Corso P . 6 . The effectiveness of interventions to increase physical activity. A systematic review . American Journal of Preventive Medicine . 22 . 4 Suppl . 73–107 . May 2002 . 11985936 . 10.1016/S0749-3797(02)00434-8 .
  32. Web site: www.paho.org . Pan American Health Organization . January 10, 2009.
  33. News: World's first standing classroom launched in Australia - The Times of India. The Times Of India .
  34. Baron M . Commercial weight-loss programs . Health Care Food & Nutrition Focus . 21 . 11 . 8–9 . November 2004 . 15559885 .
  35. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX . 6 . Weight loss with self-help compared with a structured commercial program: a randomized trial . JAMA . 289 . 14 . 1792–1798 . April 2003 . 12684357 . 10.1001/jama.289.14.1792 .
  36. Atallah R, Filion KB, Wakil SM, Genest J, Joseph L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ . 6 . Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials . Circulation: Cardiovascular Quality and Outcomes . 7 . 6 . 815–827 . November 2014 . 25387778 . 10.1161/CIRCOUTCOMES.113.000723 . Systematic review of RCTs .
  37. Vakil RM, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Lee CJ, Bleich SN, Clark JM, Gudzune KA . 6 . Direct comparisons of commercial weight-loss programs on weight, waist circumference, and blood pressure: a systematic review . BMC Public Health . 16 . 460 . June 2016 . 27246464 . 4888663 . 10.1186/s12889-016-3112-z . Systematic review . free .
  38. Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, Lee CJ, Bleich SN, Clark JM . 6 . Efficacy of commercial weight-loss programs: an updated systematic review . Annals of Internal Medicine . 162 . 7 . 501–512 . April 2015 . 25844997 . 4446719 . 10.7326/M14-2238 . Systematic review .
  39. Tsai AG, Wadden TA . Systematic review: an evaluation of major commercial weight loss programs in the United States . Annals of Internal Medicine . 142 . 1 . 56–66 . January 2005 . 15630109 . 10.7326/0003-4819-142-1-200501040-00012 . 2589699 .
  40. News: Hewitt D . China battles obesity. BBC. May 23, 2000. August 8, 2009.
  41. News: MacLeod C . Obesity of China's kids stuns officials. USA Today. August 1, 2007. August 8, 2009.
  42. Weiss EC, Galuska DA, Kettel Khan L, Gillespie C, Serdula MK . Weight regain in U.S. adults who experienced substantial weight loss, 1999-2002 . American Journal of Preventive Medicine . 33 . 1 . 34–40 . July 2007 . 17572309 . 10.1016/j.amepre.2007.02.040 .
  43. Web site: Fischer . Kathrin . 2023-09-25 . Weight regain does not eliminate the benefits of weight management programmes . 2023-09-25 . NIHR Evidence . en-GB.
  44. Hartmann-Boyce . Jamie . Theodoulou . Annika . Oke . Jason L. . Butler . Ailsa R. . Bastounis . Anastasios . Dunnigan . Anna . Byadya . Rimu . Cobiac . Linda J. . Scarborough . Peter . Hobbs . F.D. Richard . Sniehotta . Falko F. . Jebb . Susan A. . Aveyard . Paul . April 2023 . Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis . Circulation: Cardiovascular Quality and Outcomes . en . 16 . 4 . 10.1161/CIRCOUTCOMES.122.009348 . 1941-7713 . 10106109 . 36974678.
  45. 2021-08-27 . Group programmes for weight loss may be more effective than one-to-one sessions . NIHR Evidence . Plain English summary . en . 10.3310/alert_47460. 241732368 .
  46. Abbott S, Smith E, Tighe B, Lycett D . Group versus one-to-one multi-component lifestyle interventions for weight management: a systematic review and meta-analysis of randomised controlled trials . Journal of Human Nutrition and Dietetics . 34 . 3 . 485–493 . June 2021 . 33368624 . 10.1111/jhn.12853 . 229691531 .
  47. Kernan WN, Inzucchi SE, Sawan C, Macko RF, Furie KL . Obesity: a stubbornly obvious target for stroke prevention . Stroke . 44 . 1 . 278–286 . January 2013 . 23111440 . 10.1161/STROKEAHA.111.639922 . Review . free .
  48. Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, Lee CJ, Bleich SN, Clark JM . 6 . Efficacy of commercial weight-loss programs: an updated systematic review . Annals of Internal Medicine . 162 . 7 . 501–512 . April 2015 . 25844997 . 4446719 . 10.7326/M14-2238 .
  49. Book: Allan K . Hankey C . Advanced nutrition and dietetics in obesity . 2018 . Wiley . 9780470670767 . 164–168 . en . 4.4 Group‐based interventions for weight loss in obesity..
  50. Anderson JW, Konz EC, Frederich RC, Wood CL . Long-term weight-loss maintenance: a meta-analysis of US studies . The American Journal of Clinical Nutrition . 74 . 5 . 579–584 . November 2001 . 11684524 . 10.1093/ajcn/74.5.579 . Meta-analysis . free .
  51. Wing RR, Phelan S . Long-term weight loss maintenance . The American Journal of Clinical Nutrition . 82 . 1 Suppl . 222S–225S . July 2005 . 16002825 . 10.1093/ajcn/82.1.222S . free .
  52. Book: Avery A . Hankey C . Advanced nutrition and dietetics in obesity . 2018 . Wiley . 9780470670767 . 177–182 . en . 4.7 Commercial weight management organisations for weight loss in obesity..
  53. Mastellos N, Gunn LH, Felix LM, Car J, Majeed A . Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults . The Cochrane Database of Systematic Reviews . 2014 . 2 . CD008066 . February 2014 . 24500864 . 10.1002/14651858.CD008066.pub3 . 10088065 . Cochrane Metabolic and Endocrine Disorders Group .
  54. Web site: June 27, 2012 . FDA approves Belviq to treat some overweight or obese adults . 8 July 2012 . FDA.
  55. Web site: WIN – Publication – Prescription Medications for the Treatment of Obesity . . National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) . January 14, 2009 . https://web.archive.org/web/20090113185440/http://win.niddk.nih.gov/publications/prescription.htm#fdameds . January 13, 2009 . dead .
  56. Web site: www.fda.gov . .
  57. Web site: Office of the Commissioner. 2021-06-21 . FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 . 2022-07-19 . FDA . en.
  58. Web site: FDA approves weight-management drug Qsymia . . July 17, 2012.
  59. Web site: April 2014 . Evekeo Prescribing Information . 11 August 2015 . Arbor Pharmaceuticals LLC . 1–2.
  60. Siskind DJ, Leung J, Russell AW, Wysoczanski D, Kisely S . Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis . PLOS ONE . 11 . 6 . e0156208 . 2016-06-15 . 27304831 . 4909277 . 10.1371/journal.pone.0156208 . 2016PLoSO..1156208S . free . Holscher C .
  61. ((UK Prospective Diabetes Study (UKPDS) Group)) . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group . Lancet . 352 . 9131 . 854–865 . September 1998 . 9742977 . 10.1016/S0140-6736(98)07037-8 . 19208426 .
  62. Fonseca V . Effect of thiazolidinediones on body weight in patients with diabetes mellitus . The American Journal of Medicine . 115 . Suppl 8A . 42S–48S . December 2003 . 14678865 . 10.1016/j.amjmed.2003.09.005 .
  63. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J . Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus . The Cochrane Database of Systematic Reviews . 2005 . 1 . CD004096 . January 2005 . 15674929 . 6718205 . 10.1002/14651858.CD004096.pub2 .
  64. News: January 2, 2007 . Anti-obesity drug no magic bullet . . 2008-09-19.
  65. Web site: June 13, 2007 . FDA Briefing Document NDA 21-888 Zimulti (rimonabant) Tablets, 20 mg Sanofi Aventis Advisory Committee . 2008-09-19 . Food and Drug Administration.
  66. Web site: www.emea.europa.eu .
  67. Web site: 2012-10-23 . Abbott Laboratories Voluntarily Withdraws Weight-loss Drug Sibutramine (Meridia) from the Canadian Market - Health Canada Information Update 2010-10-08 .
  68. Web site: www.nice.org.uk . dead . https://web.archive.org/web/20101106130516/http://www.nice.org.uk/nicemedia/live/11000/30364/30364.pdf . 2010-11-06.
  69. Web site: Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review . Food and Drug Administration.
  70. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL . 6 . Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects . The New England Journal of Medicine . 363 . 10 . 905–917 . September 2010 . 20818901 . 10.1056/NEJMoa1003114 . free . 2437/111825 .
  71. Rados C . Ephedra ban: no shortage of reasons . FDA Consumer . 38 . 2 . 6–7 . 2004 . 15101356 .
  72. Web site: Lorcaserin (Belviq) Withdrawn From US Market Due to Cancer Risk . 2022-07-19 . Medscape . en.
  73. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS . Narrative review: the role of leptin in human physiology: emerging clinical applications . Annals of Internal Medicine . 152 . 2 . 93–100 . January 2010 . 20083828 . 2829242 . 10.7326/0003-4819-152-2-201001190-00008 .
  74. Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J . Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials . Obesity Reviews . 15 . 6 . 528–537 . June 2014 . 24528624 . 10.1111/obr.12162 . 8660739 .
  75. Maunder A, Bessell E, Lauche R, Adams J, Sainsbury A, Fuller NR . Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis of randomized controlled trials . Diabetes, Obesity & Metabolism . 22 . 6 . 891–903 . June 2020 . 31984610 . 10.1111/dom.13973 .
  76. Book: https://books.google.com/books?id=IXLdBgAAQBAJ&pg=PA70 . Endoscopic Treatment of Obesity . Gastrointestinal Endoscopy: New Technologies and Changing Paradigms . Sullivan S . Jonnalagadda SS . Springer . 61–82 . 2015 . 9781493920327 . 18 March 2016.
  77. Book: https://books.google.com/books?id=HHmBCgAAQBAJ&pg=PA494 . Chapter 51: Endoscopic Duodenal-Jejunal Bypass Sleeve Treatment for Obesity . Obesity, Bariatric and Metabolic Surgery: A Practical Guide . Muñoz R, Escalona A . Agrawal S . Springer . 493–498 . 2015 . 9783319043432 . 18 March 2016.
  78. Encinosa WE, Bernard DM, Chen CC, Steiner CA . Healthcare utilization and outcomes after bariatric surgery . Medical Care . 44 . 8 . 706–712 . August 2006 . 16862031 . 10.1097/01.mlr.0000220833.89050.ed . 8434284 .
  79. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC . 6 . Long-term mortality after gastric bypass surgery . The New England Journal of Medicine . 357 . 8 . 753–761 . August 2007 . 17715409 . 10.1056/NEJMoa066603 . 8710295 . free .
  80. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD . Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures . The American Journal of Medicine . 121 . 10 . 885–893 . October 2008 . 18823860 . 10.1016/j.amjmed.2008.05.036 .
  81. Chitturi S, Wong VW, Chan WK, Wong GL, Wong SK, Sollano J, Ni YH, Liu CJ, Lin YC, Lesmana LA, Kim SU, Hashimoto E, Hamaguchi M, Goh KL, Fan J, Duseja A, Dan YY, Chawla Y, Farrell G, Chan HL . 6 . The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups . Journal of Gastroenterology and Hepatology . 33 . 1 . 86–98 . January 2018 . 28692197 . 10.1111/jgh.13856 . 29648173 . free .
  82. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK . Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis . Clinical Gastroenterology and Hepatology . 6 . 12 . 1396–1402 . December 2008 . 18986848 . 10.1016/j.cgh.2008.08.012 .
  83. Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N, Vignaud M, Alvarez A, Singh PM, Lobo DN . 6 . Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations . World Journal of Surgery . 40 . 9 . 2065–2083 . September 2016 . 26943657 . 10.1007/s00268-016-3492-3 . Professional society guidelines . free .
  84. Holderbaum M, Casagrande DS, Sussenbach S, Buss C . Effects of very low calorie diets on liver size and weight loss in the preoperative period of bariatric surgery: a systematic review . Surgery for Obesity and Related Diseases . 14 . 2 . 237–244 . February 2018 . 29239795 . 10.1016/j.soard.2017.09.531 . Systematic review .
  85. Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, Ko CY, Gibbons MM . 6 . Does weight loss immediately before bariatric surgery improve outcomes: a systematic review . Surgery for Obesity and Related Diseases . 5 . 6 . 713–721 . 2008 . 19879814 . 10.1016/j.soard.2009.08.014 .
  86. Roman M, Monaghan A, Serraino GF, Miller D, Pathak S, Lai F, Zaccardi F, Ghanchi A, Khunti K, Davies MJ, Murphy GJ . 6 . Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes . The British Journal of Surgery . 106 . 3 . 181–189 . February 2019 . 30328098 . 10.1002/bjs.11001 . Meta-analysis . free . 2381/43636 . free .
  87. Cassie S, Menezes C, Birch DW, Shi X, Karmali S . Effect of preoperative weight loss in bariatric surgical patients: a systematic review . Surgery for Obesity and Related Diseases . 7 . 6 . 760–7; discussion 767 . 2010 . 21978748 . 10.1016/j.soard.2011.08.011 . Systematic review .
  88. Giugliano G, Nicoletti G, Grella E, Giugliano F, Esposito K, Scuderi N, D'Andrea F . Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women . British Journal of Plastic Surgery . 57 . 3 . 190–194 . April 2004 . 15006519 . 10.1016/j.bjps.2003.12.010 .
  89. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS . Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease . The New England Journal of Medicine . 350 . 25 . 2549–2557 . June 2004 . 15201411 . 10.1056/NEJMoa033179 . free .
  90. Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González-Enríquez J . Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis . Obesity Surgery . 18 . 7 . 841–846 . July 2008 . 18459025 . 10.1007/s11695-007-9331-8 . 10220216 .
  91. Web site: FDA approves first-of-kind device to treat obesity. fda.gov. 18 January 2015. January 14, 2015.
  92. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm506625.htm FDA release. June 14, 2016
  93. Kumar N . Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration . World Journal of Gastrointestinal Endoscopy . 7 . 9 . 847–859 . July 2015 . 26240686 . 4515419 . 10.4253/wjge.v7.i9.847 . free .
  94. Book: Satcher D . The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity . U.S. Dept. of Health and Human Services, Public Health Service, Office of Surgeon General . 2001 . 978-0-16-051005-2 . Publications and Reports of the Surgeon General. 20669513 .
  95. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Grossman DC, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB . 6 . Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement . JAMA . 320 . 11 . 1163–1171 . September 2018 . 30326502 . 10.1001/jama.2018.13022 . free .
  96. News: Barnes B . 18 July 2007 . Limiting Ads of Junk Food to Children . The New York Times . 24 July 2008.
  97. Web site: Fewer Sugary Drinks Key to Weight Loss . 18 October 2009 . U.S. Department of Health and Human Services.
  98. Web site: WHO urges global action to curtail consumption and health impacts of sugary drinks . 13 October 2016 . WHO.
  99. Brennan Ramirez LK, Hoehner CM, Brownson RC, Cook R, Orleans CT, Hollander M, Barker DC, Bors P, Ewing R, Killingsworth R, Petersmarck K, Schmid T, Wilkinson W . 6 . Indicators of activity-friendly communities: an evidence-based consensus process . American Journal of Preventive Medicine . 31 . 6 . 515–524 . December 2006 . 17169714 . 10.1016/j.amepre.2006.07.026 . Research Support . free .
  100. Stead M, Angus K, Langley T, Katikireddi SV, Hinds K, Hilton S, Lewis S, Thomas J, Campbell M, Young B, Bauld L . 6 . Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence . EN . Public Health Research . 7 . 8 . 1–206 . 2019-05-02 . 31046212 . 10.3310/phr07080 . free . 1893/29477 . free .
  101. 19 May 2022 . How can local authorities reduce obesity? Insights from NIHR research . NIHR Evidence . Plain English summary . National Institute for Health and Care Research.
  102. Crockett RA, King SE, Marteau TM, Prevost AT, Bignardi G, Roberts NW, Stubbs B, Hollands GJ, Jebb SA . 6 . Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption . The Cochrane Database of Systematic Reviews . 2 . 2 . CD009315 . February 2018 . 29482264 . 5846184 . 10.1002/14651858.CD009315.pub2 .
  103. King . Douglas M. . Jacobson . Sheldon H. . What Is Driving Obesity? A Review on the Connections Between Obesity and Motorized Transportation . Current Obesity Reports . 1 March 2017 . 6 . 1 . 3–9 . 10.1007/s13679-017-0238-y . en . 2162-4968.
  104. McCormack . Gavin R. . Virk . Jagdeep S. . Driving towards obesity: A systematized literature review on the association between motor vehicle travel time and distance and weight status in adults . Preventive Medicine . 1 September 2014 . 66 . 49–55 . 10.1016/j.ypmed.2014.06.002 . 0091-7435. 1880/115549 . free .
  105. Web site: Obesity Guidelines Website . Australian Government Department of Health and Ageing . Oct 25, 2009.
  106. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus-Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Zahorska-Markiewicz B . 6 . Management of obesity in adults: European clinical practice guidelines . Obesity Facts . 1 . 2 . 106–116 . April 2008 . 20054170 . 6452117 . 10.1159/000126822 . Obesity Management Task Force of the European Association for the Study of Obesity .
  107. Web site: 2014-11-27 . Overview Obesity: identification, assessment and management Guidance NICE . 2024-08-08 . www.nice.org.uk.
  108. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K . Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians . Annals of Internal Medicine . 142 . 7 . 525–531 . April 2005 . 15809464 . 10.7326/0003-4819-142-7-200504050-00011 . Clinical Efficacy Assessment Subcommittee of the American College of Physicians . Fulltext.
  109. Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale . American Family Physician . 67 . 12 . 2573–2576 . June 2003 . 12825847 . 2014-02-24 . dead . https://archive.today/20140224143303/http://www.uspreventiveservicestaskforce.org/3rduspstf/diet/dietrr.htm . 2014-02-24 . U.S. Preventive Services Task Force .
  110. Pignone MP, Ammerman A, Fernandez L, Orleans CT, Pender N, Woolf S, Lohr KN, Sutton S . 6 . Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force . American Journal of Preventive Medicine . 24 . 1 . 75–92 . January 2003 . 12554027 . 10.1016/S0749-3797(02)00580-9 .
  111. Mathur MB, Mathur VS . Primary Care Physicians' Perceptions of the Effects of Being Overweight on All-cause Mortality . en-US . Epidemiology . 34 . 3 . e19–e20 . May 2023 . 36727941 . 10.1097/EDE.0000000000001590 . 256499920 . 10368371 .
  112. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF . 6 . 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society . Circulation . 129 . 25 Suppl 2 . S102–S138 . June 2014 . 24222017 . 5819889 . 10.1161/01.cir.0000437739.71477.ee .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Management of obesity".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.